DUBLIN–(BUSINESS WIRE)–The “Global Age-Related Macular Degeneration Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering. The Global Age-Related Macular Degeneration Market is expected to reach $15,882.7 million by 2026 gr…
Author: Business Wire
Global Optical Biometry Devices Market 2019-2023 | Evolving Opportunities with Carl Zeiss Meditec AG and Menicon Co. Ltd. | Technavio
LONDON–(BUSINESS WIRE)– #healthcare–Technavio has been monitoring the global optical biometry devices market and the market is poised to grow by USD 83.77 million during 2019-2023
Alcon Reports Third Quarter and Nine Months 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter and Nine Months 2019 Results
Alcon Reports Third Quarter and Nine Months 2019 Results
GENEVA–(BUSINESS WIRE)–Alcon Reports Third Quarter and Nine Months 2019 Results
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in accordance with …
NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the launch of NovaSight™, a proprietary daily vitamin and mineral supplement specially formulated to support ocular health, on Amazon.com. NovaSight is a…
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma, S.L. to Advance Its Dry Eye Program
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (“Aerie”), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-ang…
Second Sight Reports Third Quarter 2019 Financial Results
LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision…
Ocular Therapeutix™ to Present at the Jefferies 2019 London Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
Armenian EyeCare Project Surpasses Milestone of 10,000 Patients Screened Using Artificial Intelligence Eye Screening Technology
YEREVAN, Armenia–(BUSINESS WIRE)–On this World Diabetes Day, the Armenian EyeCare Project (AECP), a nonprofit organization dedicated to eliminating preventable blindness in Armenia, announced that it has surpassed the milestone of screening 10,000 pa…
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Independent Reviewed Data Released from the AMPECT Registration Trial in Advanced PEComa
PACIFIC PALISADES, Calif.–(BUSINESS WIRE)–Aadi Bioscience, Inc. (Aadi), a privately held clinical stage biopharmaceutical company, today released its independent radiology reviewed data from the nab-sirolimus (ABI-009) registration trial (AMPECT) for…
MJH Life Sciences™ Publications Win Big at 2019 Folio: Eddie and Ozzie Awards Gala
CRANBURY, N.J.–(BUSINESS WIRE)– #FolioAwards–Three MJH Life Sciences™ Publications won first place across a range of categories at this year’s Folio: Eddie and Ozzie Awards gala
ELT Sight Acquires Assets and IP of MLase AG Excimer Ophthalmic Laser System for Glaucoma Surgery
LOS ANGELES & MUNICH–(BUSINESS WIRE)–ELT Sight acquires assets and IP of MLase AG excimer ophthalmic laser system for implant-free microinvasive glaucoma surgery.
Lineage Cell Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, reported financial and operating resul…
Global Vision Care Devices & Equipment Market Report 2020 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Vision Care Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global vision care devices and equipment market was valued at about $27.6 billion in 2018 and is …
Aerie Pharmaceuticals to Present at the Stifel 2019 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
IVERIC bio Reports Third Quarter 2019 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio today provided an overview of the Company’s financial results for the third quarter 2019 and provided a general business update.
IVERIC bio Initiating Second Pivotal Clinical Trial of Zimura® in GA with 1Q 2020 Targeted for First Patient Enrolled
NEW YORK–(BUSINESS WIRE)–IVERIC bio provided further clinical details and its development strategy for Zimura for the treatment of geographic atrophy secondary to dry AMD.
Ocular Therapeutix™ Reports Third Quarter 2019 Financial Results and Business Update
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Dakon Montgomery Joins Eyecare Services Partners as Chief Operating Officer
DALLAS–(BUSINESS WIRE)–Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Dakon H. Montgomery as Chief Operating Officer, effective today. Mr. Montgomery comes to ESP with 12 years of le…